Explore more publications!
Trinidad & Tobago STEM News
Got News to Share?

Trinidad & Tobago STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Trinidad & Tobago STEM News.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on April 30, 2026

The Architect of Culture and Command: The Nu-Age Group Appoints Derick Diaz as Vice President of Technology
Apr. 30, 2026

The Architect of Culture and Command: The Nu-Age Group Appoints Derick Diaz as Vice President of Technology

Indeterminate EIN Presswire
Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering
Apr. 30, 2026

Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering

Indeterminate GlobeNewswire
TransAlta Corporation Announces Results of the 2026 Annual and Special Meeting of Shareholders and Election of all Directors
Apr. 30, 2026

TransAlta Corporation Announces Results of the 2026 Annual and Special Meeting of Shareholders and Election of all Directors

Indeterminate GlobeNewswire
Svitla Systems Acquires Australia’s Kiandra IT to Expand Global Engineering Footprint and Accelerate AI-Driven Delivery
Apr. 30, 2026

Svitla Systems Acquires Australia’s Kiandra IT to Expand Global Engineering Footprint and Accelerate AI-Driven Delivery

Indeterminate GlobeNewswire
Totus Medicines to Present Interim Phase 1b Clinical Data for TOS-358 + Fulvestrant Doublet Therapy in HR+/HER- Breast Cancer Patients at ESMO Breast Cancer Annual Congress 2026
Apr. 30, 2026

Totus Medicines to Present Interim Phase 1b Clinical Data for TOS-358 + Fulvestrant Doublet Therapy in HR+/HER- Breast Cancer Patients at ESMO Breast Cancer Annual Congress 2026

Indeterminate GlobeNewswire
TLX101-Px (Pixlumi®) MAA Accepted in Europe
Apr. 30, 2026

TLX101-Px (Pixlumi®) MAA Accepted in Europe

Indeterminate GlobeNewswire
TTEC Recognized as a Major Contender in Everest Group’s 2026 Healthcare CXM Intelligent Operations PEAK Matrix® Assessment
Apr. 30, 2026

TTEC Recognized as a Major Contender in Everest Group’s 2026 Healthcare CXM Intelligent Operations PEAK Matrix® Assessment

Indeterminate GlobeNewswire
Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update
Apr. 30, 2026

Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Inventronics Announces 2026 Q1 Financial Results
Apr. 30, 2026

Inventronics Announces 2026 Q1 Financial Results

Indeterminate GlobeNewswire
Juvthorix Unveiled: Should You Join Juvthorix? Hidden Features, Performance, Fees & Real User Insights!
Apr. 30, 2026

Juvthorix Unveiled: Should You Join Juvthorix? Hidden Features, Performance, Fees & Real User Insights!

Indeterminate GlobeNewswire
WISeKey Reports Audited Full Year 2025 Financial Results
Apr. 30, 2026

WISeKey Reports Audited Full Year 2025 Financial Results

Indeterminate GlobeNewswire
reAlpha (NASDAQ: AIRE) Announces AiChat Launch of Shopify Conversational Commerce Integration and AI Ticketing for eCommerce
Apr. 30, 2026

reAlpha (NASDAQ: AIRE) Announces AiChat Launch of Shopify Conversational Commerce Integration and AI Ticketing for eCommerce

Indeterminate GlobeNewswire
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
Apr. 30, 2026

TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues

Indeterminate GlobeNewswire
DBV Technologies Reports First Quarter 2026 Financial Results
Apr. 30, 2026

DBV Technologies Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
DBV Technologies publie ses résultats financiers du 1er trimestre 2026
Apr. 30, 2026

DBV Technologies publie ses résultats financiers du 1er trimestre 2026

Indeterminate GlobeNewswire
Alvotech Announces a Change in its Executive Team
Apr. 30, 2026

Alvotech Announces a Change in its Executive Team

Indeterminate GlobeNewswire
Cue Biopharma Announces $30 Million Private Placement
Apr. 30, 2026

Cue Biopharma Announces $30 Million Private Placement

Indeterminate GlobeNewswire
HCW Biologics Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum
Apr. 30, 2026

HCW Biologics Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum

Indeterminate GlobeNewswire
Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody
Apr. 30, 2026

Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody

Indeterminate GlobeNewswire
Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026
Apr. 30, 2026

Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions